Geeta Mehta, Ph.D.
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Receptor mediated cell behaviorGoogle:
"Geeta Mehta"Mean distance: 16.94 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Jennifer J. Linderman | grad student | 2008 | University of Michigan | |
| (Microenvironmental control in microfluidic bioreactors for long term culture of bone marrow cells.) | ||||
Children
Sign in to add trainee| Shreya Raghavan | post-doc | 2014-2019 | University of Michigan (BME Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burkhard KM, Mehta G. (2024) Multicellular Tumoroids for Investigating Cancer Stem-Like Cells in the Heterogeneous Tumor Microenvironment. Methods in Molecular Biology (Clifton, N.J.). 2777: 99-122 |
| Kapur A, Mehta P, Simmons AD, et al. (2022) Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers. Cancers. 14 |
| Horst EN, Novak CM, Burkhard K, et al. (2022) Injectable three-dimensional tumor microenvironments to study mechanobiology in ovarian cancer. Acta Biomaterialia |
| Bregenzer M, Horst E, Mehta P, et al. (2022) The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods. Methods in Molecular Biology (Clifton, N.J.). 2424: 217-245 |
| Horst EN, Bregenzer ME, Mehta P, et al. (2021) Personalized Models of Heterogenous 3D Epithelial Tumor Microenvironments: Ovarian Cancer as a Model. Acta Biomaterialia |
| Chesnokov MS, Khan I, Park Y, et al. (2021) The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma. Cancers. 13 |
| Raghavan S, Snyder CS, Wang A, et al. (2020) Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling. Cancers. 12 |
| Novak CM, Horst EN, Lin E, et al. (2020) Compressive Stimulation Enhances Ovarian Cancer Proliferation, Invasion, Chemoresistance, and Mechanotransduction via CDC42 in a 3D Bioreactor. Cancers. 12 |
| Brown JR, Chan DK, Shank JJ, et al. (2020) Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer. Jci Insight |
| Rivera-Báez L, Lohse I, Lin E, et al. (2020) Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine. Cancers. 12 |